Johnson & Johnson has withdrawn its proposal seeking approval of its single-shot Covid-19 vaccine in India, Drugs Controller General of India (DCGI) sources said. Johnson & Johnson has not cited any reason for the withdrawal yet. The US-based company had sought approval in April to conduct a bridging clinical study of its Janssen Covid-19 vaccine candidate in India. It was reported earlier that a few thousand doses of Johnson & Johnson's vaccine could arrive in India in July.

Johnson & Johnson has withdrawn its proposal seeking approval of its single-shot Covid-19 vaccine in India, Drugs Controller General of India (DCGI) sources said. Johnson & Johnson has not cited any reason for the withdrawal yet. The US-based company had sought approval in April to conduct a bridging clinical study of its Janssen Covid-19 vaccine candidate in India. It was reported earlier that a few thousand doses of Johnson & Johnson's vaccine could arrive in India in July.